specific for an epitope mapping between amino acids 3-27 at the N-terminus of HPV18 E7 of viral origin.
Key Feature
Clonality
monoclonal
Isotype
IgG1, k
Host Species
Mouse
Tested Applications
ICC/IFWB
WB:1:100-1:1000 ICC/IF:1:50-1:500
Species Reactivity
Human
Concentration
0.2mg/ml
Purification
Affinity purified
Target Information
Target
Human papilloma viruses (HPVs) can be classified as either high risk or low
risk according to their association with cancer. HPV16 and HPV18 are the
most common of the high risk group, while HPV6 and HPV11 are among the
low risk types. Approximately 90% of cervical cancers contain HPV DNA
of the high risk types. Mutational analysis have shown that the E6 and E7
genes of the high risk HPVs are necessary and sufficient for HPV transforming
function. The specific interactions of the E6 and E7 proteins with p53 and
pRB, respectively, correlate with HPV high and low risk classifications. The
high risk HPV E7 proteins bind to pRB with a higher affinity than do the low
risk HPV proteins, and only the high risk HPV E6 proteins form detectable
complexes with p53 in vitro.
Molecular Weight(MW)
15 kDa
Cellular Localization
nuclear,cytoplasmic.
Application
WB
Western blot analysis of HPV18 E7 expression in HeLa whole cell lysate.
ICC/IF
Immunofluorescence staining of methanol fixed HeLa cells revealed nuclear and cytoplasmic localization.
Application Notes
WB:1:100-1:1000 ICC/IF:1:50-1:500
Additional Information
Form
Liquid
Storage Instructions
Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of shipment. Non-hazardous. No MSDS required.
Storage Buffer
Each vial contains 50 µg IgG1 kappa light chain in 0.5 ml of PBS with < 0.1% sodium azide and 0.1% gelatin.